Colection of clinical data
OtherColection of clinical data
NCT Number: NCT03767049
A multi-centre, prospective and observational study was carried out from August 2012 to June 2016 in five Spanish tertiary-care university hospitals with well-established lung transplant programs: Vall d'Hebron (Barcelona), Marqués de Valdecilla (Santander), 12 de Octubre (Madrid), CHUAC (A Coruña), and Reina Sofía (Córdoba).
The study population comprised all consecutive adult lung transplant recipients who required ICUr (after >7 days post-transplant discharge from ICU) during august 2012 - June 2016 (4-yr period).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Colection of clinical data
Time frame: Augist 1. 2012 - June 30, 2016
To assess the principal causes of ICU readmission in LT adults.
Time frame: Augist 1. 2012 - June 30, 2016
To identify potential predictors of ICU and hospital mortality.
Hospital Universitari Vall d'Hebron Research Institute
Other
Readmissions of Lung Transplant Patients in the Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05916495
Lung Transplant; Complications
Manchester, United Kingdom
View Trial DetailsNCT03656926
Behavior, Bronchial Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03657342
Behavior, Bronchial Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05691205
Cardiovascular Diseases, Lung Transplant; Complications
Milan, Italy
View Trial Details